| Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients M Varettoni, A Corso, G Pica, S Mangiacavalli, C Pascutto, M Lazzarino Annals of Oncology 21 (2), 325-330, 2010 | 616 | 2010 |
| MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele … L Xu, ZR Hunter, G Yang, Y Zhou, Y Cao, X Liu, E Morra, A Trojani, ... Blood, The Journal of the American Society of Hematology 121 (11), 2051-2058, 2013 | 457 | 2013 |
| Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms M Varettoni, L Arcaini, S Zibellini, E Boveri, S Rattotti, R Riboni, A Corso, ... Blood, The Journal of the American Society of Hematology 121 (13), 2522-2528, 2013 | 376 | 2013 |
| Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia E Tiacci, JH Park, L De Carolis, SS Chung, A Broccoli, S Scott, F Zaja, ... New England Journal of Medicine 373 (18), 1733-1747, 2015 | 360 | 2015 |
| Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients F Passamonti, E Rumi, L Arcaini, E Boveri, C Elena, D Pietra, S Boggi, ... haematologica 93 (11), 1645-1651, 2008 | 335 | 2008 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 273 | 2020 |
| The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms L Arcaini, S Zibellini, E Boveri, R Riboni, S Rattotti, M Varettoni, ... Blood, The Journal of the American Society of Hematology 119 (1), 188-191, 2012 | 194 | 2012 |
| Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi L Arcaini, D Vallisa, S Rattotti, VV Ferretti, AJM Ferreri, P Bernuzzi, ... Annals of Oncology 25 (7), 1404-1410, 2014 | 178 | 2014 |
| Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases EP Alessandrino, P Bernasconi, D Caldera, A Colombo, M Bonfichi, ... Bone Marrow Transplantation 23 (6), 533-537, 1999 | 176 | 1999 |
| Clonal architecture of CXCR4 WHIM‐like mutations in Waldenström Macroglobulinaemia L Xu, ZR Hunter, N Tsakmaklis, Y Cao, G Yang, J Chen, X Liu, S Kanan, ... British journal of haematology 172 (5), 735-744, 2016 | 149 | 2016 |
| A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma A Corso, M Varettoni, P Zappasodi, C Klersy, S Mangiacavalli, G Pica, ... Leukemia 21 (7), 1545-1548, 2007 | 147 | 2007 |
| Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia JJ Castillo, RH Advani, AR Branagan, C Buske, MA Dimopoulos, S D'Sa, ... The Lancet Haematology 7 (11), e827-e837, 2020 | 135 | 2020 |
| Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease A Tedeschi, G Benevolo, M Varettoni, ML Battista, PL Zinzani, C Visco, ... Cancer 118 (2), 434-443, 2012 | 125 | 2012 |
| Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma S Zibellini, D Capello, F Forconi, P Marcatili, D Rossi, S Rattotti, ... haematologica 95 (10), 1792, 2010 | 113 | 2010 |
| Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study JJ Castillo, S D'Sa, MP Lunn, MC Minnema, A Tedeschi, F Lansigan, ... British Journal of Haematology 172 (5), 709-715, 2016 | 112 | 2016 |
| Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance M Varettoni, S Zibellini, I Defrancesco, VV Ferretti, E Rizzo, L Malcovati, ... Haematologica 102 (12), 2077, 2017 | 110 | 2017 |
| Immune-mediated neuropathies in myeloma patients treated with bortezomib S Ravaglia, A Corso, G Piccolo, A Lozza, E Alfonsi, S Mangiacavalli, ... Clinical neurophysiology 119 (11), 2507-2512, 2008 | 106 | 2008 |
| Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients A Corso, S Mangiacavalli, M Varettoni, C Pascutto, P Zappasodi, ... Leukemia research 34 (4), 471-474, 2010 | 101 | 2010 |
| Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study JJ Castillo, G Itchaki, J Paludo, M Varettoni, C Buske, TA Eyre, JC Chavez, ... Blood, The Journal of the American Society of Hematology 133 (4), 299-305, 2019 | 95 | 2019 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 93 | 2021 |
Luca ArcainiDepartment of Molecular Medicine, University of PaviaEmail verificata su unipv.it
